SPONSOR
Queen Mary University of London
Total Trials
7
Recruiting
7
Phases
Phase 1
Conditions studied: Primary AldosteronismHigh Blood PressurePeriodontal DiseasesObstructive Sleep ApneaRelapsing Remitting Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisWound HealPeriodontal InflammationPeriodontal Pocket
Queen Mary University of London is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Primary Aldosteronism, High Blood Pressure, Periodontal Diseases, Obstructive Sleep Apnea.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Queen Mary University of London
How many clinical trials has Queen Mary University of London sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Queen Mary University of London, of which 7 are actively recruiting participants. These trials cover conditions including Primary Aldosteronism, High Blood Pressure, Periodontal Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Queen Mary University of London research focus on?
Queen Mary University of London clinical trials span Primary Aldosteronism, High Blood Pressure, Periodontal Diseases, Obstructive Sleep Apnea, Relapsing Remitting Multiple Sclerosis, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Queen Mary University of London clinical trial?
To participate in a Queen Mary University of London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Queen Mary University of London trials with current recruitment status updated daily.
Clinical Trials by Queen Mary University of London
NCT05765786
Recruiting
Diagnosing Variable Primary Aldosteronism.
Primary Aldosteronism
NCT04254861
Recruiting
Autologous Platelet Concentrate (APC) in Intrabony Defects
Periodontal Diseases
NCT04092660
Recruiting
Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway Collapse During Sleep in Patients With Obstructive Sleep Apnoea.
Obstructive Sleep Apnea
NCT03783416 Phase 1
Recruiting
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
Relapsing Remitting Multiple Sclerosis
NCT06309719
Recruiting
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
Periodontal Diseases
NCT07035691
Recruiting
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
Colorectal Carcinoma
NCT06963567
Recruiting
Left Ventricular Thrombus Registry
Left Ventricular Thrombus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology